Nothing Special   »   [go: up one dir, main page]

IL85943A0 - 5-substituted quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions and feed additives containing them - Google Patents

5-substituted quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions and feed additives containing them

Info

Publication number
IL85943A0
IL85943A0 IL85943A IL8594388A IL85943A0 IL 85943 A0 IL85943 A0 IL 85943A0 IL 85943 A IL85943 A IL 85943A IL 8594388 A IL8594388 A IL 8594388A IL 85943 A0 IL85943 A0 IL 85943A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
acid derivatives
feed additives
additives containing
Prior art date
Application number
IL85943A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL85943A0 publication Critical patent/IL85943A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL85943A 1987-04-02 1988-03-31 5-substituted quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions and feed additives containing them IL85943A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873711193 DE3711193A1 (en) 1987-04-02 1987-04-02 5-SUBSTITUTED CHINOLON AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES

Publications (1)

Publication Number Publication Date
IL85943A0 true IL85943A0 (en) 1988-09-30

Family

ID=6324762

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85943A IL85943A0 (en) 1987-04-02 1988-03-31 5-substituted quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions and feed additives containing them

Country Status (14)

Country Link
EP (1) EP0284935A1 (en)
JP (1) JPS63258855A (en)
KR (1) KR880012593A (en)
CN (1) CN88101741A (en)
AU (1) AU1381188A (en)
DD (1) DD274029A5 (en)
DE (1) DE3711193A1 (en)
DK (1) DK180288A (en)
FI (1) FI881501A (en)
HU (1) HU201050B (en)
IL (1) IL85943A0 (en)
NO (1) NO881121L (en)
PT (1) PT87124B (en)
ZA (1) ZA882318B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
JPS649992A (en) * 1987-06-30 1989-01-13 Dainippon Pharmaceutical Co 1,8-crosslinked quinolincarboxylic acid derivative, ester thereof and salt thereof
US4839355A (en) * 1987-09-09 1989-06-13 Sterling Drug Inc. Tricyclic-pyridinylquinoline compounds, their preparation and use
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
JPH0228178A (en) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd Novel pyridonecarboxylic acid derivative and salt thereof
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (en) * 1988-06-21 1994-09-21 塩野義製薬株式会社 Quinolonecarboxylic acid derivative
FI901201A0 (en) * 1989-03-13 1990-03-09 Bristol Myers Squibb Co ANTIBAKTERIELLA 5-SUBSTITUERADE 1,4-DIHYDRO-4-OXONAFTYRIDIN-3-CARBOXYLATDERIVAT OCH DERAS FRAMSTAELLNING.
WO1990012799A1 (en) * 1989-04-26 1990-11-01 The Upjohn Company Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991016327A1 (en) 1990-04-18 1991-10-31 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
DE4032560A1 (en) * 1990-10-13 1992-04-16 Bayer Ag 7- (2,7-DIAZABICYCLO (3.3.0) OCTYL) -3-CHINOLON AND -NAPHTYRIDONCARBONIC ACID DERIVATIVES
FR2681863B1 (en) * 1991-09-27 1995-02-03 Rhone Dpc Europ SOLUTION OF SPARFLOXACIN, ITS PREPARATION AND SALT CONSTITUTING IT.
WO1993013101A1 (en) * 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
TW252107B (en) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
AU697025B2 (en) * 1995-01-24 1998-09-24 Hokuriku Seiyaku Co. Ltd Quinoline carboxylic acid
DE10108750A1 (en) 2001-02-23 2002-09-05 Bayer Ag Improved process for the production of fluoroquinolonecarboxylic acids
WO2004024729A1 (en) * 2002-09-10 2004-03-25 Pfizer Products Inc. Diazabicyclic compounds useful in the treatment of cns and other disorders
US7514451B2 (en) 2003-09-10 2009-04-07 Kyorin Pharmaceutical Co., Ltd. 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
EP2522670A1 (en) 2004-04-07 2012-11-14 Takeda Pharmaceutical Company Limited Heterocyclic CRF receptor antagonists
CA2688008A1 (en) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN105037388A (en) * 2015-08-28 2015-11-11 安徽环球药业股份有限公司 Preparing method for antofloxacin
CN109251211A (en) * 2016-12-21 2019-01-22 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） A kind of quinolonecarboxylic acid compound and its intermediate, preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59137482A (en) * 1983-01-26 1984-08-07 Otsuka Pharmaceut Co Ltd Pyrrolo(3,2,1,-ij)quinoline-5-carboxylic acid derivative
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof

Also Published As

Publication number Publication date
NO881121D0 (en) 1988-03-14
NO881121L (en) 1988-10-03
DK180288D0 (en) 1988-03-30
EP0284935A1 (en) 1988-10-05
DD274029A5 (en) 1989-12-06
ZA882318B (en) 1988-10-04
HU201050B (en) 1990-09-28
PT87124B (en) 1992-07-31
FI881501A0 (en) 1988-03-30
DE3711193A1 (en) 1988-10-13
FI881501A (en) 1988-10-03
AU1381188A (en) 1988-10-06
JPS63258855A (en) 1988-10-26
DK180288A (en) 1988-10-03
HUT47098A (en) 1989-01-30
PT87124A (en) 1988-04-01
CN88101741A (en) 1988-11-16
KR880012593A (en) 1988-11-28

Similar Documents

Publication Publication Date Title
IL85943A0 (en) 5-substituted quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions and feed additives containing them
IL76453A (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69347A (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL86551A0 (en) (1h-azol-1-ylmethyl)substituted benzotriazole derivatives,their preparation and pharmaceutical compositions containing them
IL78111A0 (en) Sulfur-containing 5-substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL78942A0 (en) Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL74826A (en) 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL87181A (en) Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them
IL87871A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL87435A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL81179A0 (en) Azine acid derivatives,their preparation and pharmaceutical compositions containing them
IL73840A (en) 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them
IL83049A (en) 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
IL84808A0 (en) Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them
IL72716A (en) 5-phenylcarbamoyl barbituric acid derivatives,their preparation and anthelmintic compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL86478A0 (en) Substituted vinylcephalosporins,their preparation and pharmaceutical compositions containing them
IL88003A0 (en) Quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL75913A0 (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL87130A0 (en) Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL87209A0 (en) Benzimidazole derivatives,their manufacture and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL70992A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them